Oncocyte CORP S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

Oncocyte Corporation has filed an S-1 registration statement with the SEC to allow selling stockholders to resell up to 10,606,632 shares of common stock acquired through a recent private placement and associated warrants.